CS259646B1 - Method of diarylmethyl-4-tetrahydrothiopyranyleters and their methiodides preparation - Google Patents
Method of diarylmethyl-4-tetrahydrothiopyranyleters and their methiodides preparation Download PDFInfo
- Publication number
- CS259646B1 CS259646B1 CS872622A CS262287A CS259646B1 CS 259646 B1 CS259646 B1 CS 259646B1 CS 872622 A CS872622 A CS 872622A CS 262287 A CS262287 A CS 262287A CS 259646 B1 CS259646 B1 CS 259646B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- preparation
- diarylmethyl
- methiodides
- reaction
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims abstract description 14
- 229910000027 potassium carbonate Inorganic materials 0.000 claims abstract description 7
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims abstract description 5
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims abstract description 5
- YODQQARABJQLIP-UHFFFAOYSA-N thian-4-ol Chemical compound OC1CCSCC1 YODQQARABJQLIP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000008096 xylene Substances 0.000 claims abstract description 5
- 238000009835 boiling Methods 0.000 claims abstract description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 3
- 150000001805 chlorine compounds Chemical class 0.000 claims description 2
- 150000003568 thioethers Chemical class 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 4
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract description 4
- 239000000739 antihistaminic agent Substances 0.000 abstract description 4
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 239000000741 silica gel Substances 0.000 abstract description 4
- 229910002027 silica gel Inorganic materials 0.000 abstract description 4
- 230000001387 anti-histamine Effects 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 238000001914 filtration Methods 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- ZDVDCDLBOLSVGM-UHFFFAOYSA-N [chloro(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(Cl)C1=CC=CC=C1 ZDVDCDLBOLSVGM-UHFFFAOYSA-N 0.000 abstract description 2
- 238000004587 chromatography analysis Methods 0.000 abstract description 2
- 239000000543 intermediate Substances 0.000 abstract description 2
- 150000003839 salts Chemical class 0.000 abstract description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical compound [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 abstract 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- -1 sulfonium salts Chemical class 0.000 description 3
- SFOLQZNRGSQAAR-UHFFFAOYSA-M 4-benzhydryloxy-1-methylthian-1-ium;iodide Chemical compound [I-].C1C[S+](C)CCC1OC(C=1C=CC=CC=1)C1=CC=CC=C1 SFOLQZNRGSQAAR-UHFFFAOYSA-M 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- OKFUYNIXBWECQY-UHFFFAOYSA-N 4-benzhydryloxythiane Chemical compound C1CSCCC1OC(C=1C=CC=CC=1)C1=CC=CC=C1 OKFUYNIXBWECQY-UHFFFAOYSA-N 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 230000003326 anti-histaminergic effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- BISQTCXKVNCDDA-UHFFFAOYSA-N thiepine Chemical compound S1C=CC=CC=C1 BISQTCXKVNCDDA-UHFFFAOYSA-N 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Řešení spadá do oblasti syntézy léčiv. Jeho předmětem je způsob přípravy diarylmethyl-4-tetrahydrothiopyranyletherů obecného vzorce I ve kterém X a Y značí atomy vodíku, nebo oba dohromady můstek —CH2S—, a jejich methojodidů. Způsob přípravy spočívá v reakci benzhydrylchloridu nebo 11-chlor- -6,ll-dihydrodibenzo[b,e]thiepinu s tetrahydrothiopyran-4-olem ve vroucím xylenu za přítomnosti bezvodého uhličitanu draselného. Látky obecného vzorce I jsou krystalické substance, které se získávají ze surových produktů filtrací nebo chromatografií přes sloupec silikagelu. Reakcí s methyljodidem při teplotě místnosti poskytují sulfoniové soli, tj. methojodidy. Látky obecného vzorce I jsou meziprodukty syntézy léčiv a jejich methojodidy zčásti vykazují antihistaminovou účinnost.The solution lies in the field of drug synthesis. It relates to a process for the preparation of diarylmethyl-4-tetrahydrothiopyranyl ethers general of Formula I wherein X and Y denote hydrogen atoms, or both together the bridge —CH2S—, and their methojodidů. The method of preparation lies in reaction of benzhydryl chloride or 11-chloro- -6,11-dihydrodibenzo [b, e] thiepine with tetrahydrothiopyran-4-ol in boiling xylene in the presence of anhydrous potassium carbonate. The compounds of formula I are crystalline substances that are derived from raw by filtration or chromatography through a silica gel column. Reaction with methyl iodide provide sulfonium at room temperature salts, i.e., methiodides. General Substances Formula I are drug synthesis intermediates and their methoiodides partially exhibit antihistamine efficiency.
Description
Vynález se týká způsobu přípravy diarylmethyl-4-tetrahydrothiopyranyletherů obecného vzorce IThe present invention relates to a process for the preparation of diarylmethyl-4-tetrahydrothiopyranyl ethers of general formula (I)
ve kterém X a Y značí atomy vodíku, nebo oba dohromady představují můstek —CH2S—, a jejich methojodidů.in which X and Y represent hydrogen atoms, or both together represent a bridge of "CH 2 S", and their methoiodides.
Látky podle vynálezu jsou meziprodukty syntézy léčiv s antihistaminovou a anticholinergickou účinností a jako takové jsou technicky významné. Jejich methojodidy (sulfoniové soli) již antihistaminovou aktivitu vykazují. Tak například 4-(benzhydryloxy) -1-methyltetrahydrothiopyraniumjodid (methojodid látky I, kde X = Y = H), který je velmi málo toxický (LDso je vyšší než 500 mg/kg orálně u myší), vykazuje v orální dávce 10 mg/kg u morčat signifikantní antihistaminový účinek v testu ochrany před bronchospasmem, vyvolávaným liistaminovým aerosolem (uvedená dávka chrání více než 50 % zvířat). V téže dávce vykazuje zřetelný účinek v testu ochrany vůči letálnímu efektu histaminu u morčat (v uvedené dávce chrání 25 % zvířat).The compounds of the invention are intermediates in the synthesis of drugs with antihistamine and anticholinergic activity and as such are technically significant. Their methojodides (sulfonium salts) already show antihistamine activity. For example, 4- (benzhydryloxy) -1-methyltetrahydrothiopyranium iodide (the methiodide of compound I, where X = Y = H), which is very toxic (LD 50 is greater than 500 mg / kg orally in mice), exhibits at an oral dose of 10 mg / kg in guinea pigs a significant antihistamine effect in the protection against bronchospasm induced by liistamine aerosol (this dose protects more than 50% of the animals). At the same dose, it shows a distinct effect in the guinea pig protection lethality test (25% of animals protect at that dose).
Způsob přípravy látek obecného vzorce I podle předloženého vynálezu spočívá v reakci chlorderivátů obecného vzorce II ve kterém X a Y značí totéž jako ve vzorci I, s tetrahydrothiopyran-4-olem za přítomnosti bezvodého uhličitanu draselného ve vroucím xylenu. Žádané produkty obecného vzorce I vznikají v dobrých výtěžcích a získají se v krystalickém stavu po filtraci nebo chromatografii jejich roztoků v benzenu na silikagelu. Všechny výchozí látky jsou známé a literární odkazy na jejich přípravu jsou uvedeny v příkladech. Reakcemi látek obecného vzorce I s methyljodidem se získají methojodidy, jejichž způsob přípravy je rovněž součástí vynálezu. Další podrobnosti provedení reakcí a způsobů izolace produktů jsou uvedeny v příkladech, jejichž účelem je ilustrovat možnosti vynálezu, ne však všechny tyto možnosti vyčerpávajícím způsobem popisovat. Látky v příkladech popsané jsou nové; jejich identita byla zajištěna jednak analýzami, jednak spektrálními metodami.The process for the preparation of the compounds of the formula I according to the invention consists in reacting the chloro derivatives of the formula II in which X and Y are the same as in formula I with tetrahydrothiopyran-4-ol in the presence of anhydrous potassium carbonate in boiling xylene. The desired products of formula (I) are formed in good yields and are obtained in a crystalline state after filtration or chromatography of their solutions in benzene on silica gel. All starting materials are known and references for their preparation are given in the examples. Reactions of the compounds of formula I with methyl iodide yield the methoiodides, the preparation of which is also part of the invention. Further details of carrying out the reactions and methods of isolating the products are given in the examples, which are intended to illustrate the possibilities of the invention, but not all of these possibilities are exhaustively described. The substances described in the examples are new; their identity was ensured both by analyzes and spectral methods.
Příklad 1 ll-( 4-Tetrahydrothiopyranyloxy j -6,11-dihydr odibenzo [ b,e ] thiepinEXAMPLE 1 11- (4-Tetrahydrothiopyranyloxy) -6,11-dihydrodibenzo [b, e] thiepine
Směs 5,3 g ll-chlor-6,ll-dihydrodibenzofb,e]thiepinu (Seidlová V. et al.: Monatsh. Chem. 96, 650, 1965), 2,75 g tetrahydrothiopyran-4-olu (Adlerová E. et al.: Collect. Czech. Chem. Commun. 24, 1 268 1959), 25 mililitrů xylenu a 5,9 g bezvodého uhličitanu draselného se míchá a vaří 7,5 hod. pod zpětným chladičem. Po ochlazení se přidá 100 ml vody a směs se extrahuje benzenem. Extrakt se promyje vodou, vysuší se uhličitanem draselným a odpaří za sníženého tlaku. Zbytek (7,0 g) se rozpustí v 50 ml benzenu a roztok se zfiltruje přes sloupec 30 g silikagelu. Kolona se promyje 200 ml benzenu a filtráty se odpaří. Získá se 5,8 g (88 procent) žádané látky, která krystaluje ze směsi ethanolu a cyklohexanu a v čistém stavu taje při 104 až 107 °C.A mixture of 5.3 g of 11-chloro-6,11-dihydrodibenzophobe] thiepine (Seidlova V. et al .: Monatsh. Chem. 96, 650, 1965), 2.75 g of tetrahydrothiopyran-4-ol (Adlerova E. et al .: Collect. Czech. Chem. Commun. 24, 1268 (1959)), 25 ml of xylene and 5.9 g of anhydrous potassium carbonate are stirred and refluxed for 7.5 hours. After cooling, 100 ml of water are added and the mixture is extracted with benzene. The extract was washed with water, dried over potassium carbonate and evaporated under reduced pressure. The residue (7.0 g) was dissolved in 50 ml of benzene and the solution was filtered through a column of 30 g of silica gel. The column is washed with 200 ml of benzene and the filtrates are evaporated. 5.8 g (88%) of the desired compound are obtained, which crystallizes from a mixture of ethanol and cyclohexane and melts in the pure state at 104-107 ° C.
Příklad 2Example 2
4- (Benzhydryloxy )-l-methyltetrahydroSměs 8,1 g benzhydrylchloridu (Gilman H., Kirby J. E.: J. Am. Chem. Soc. 48, 1 735, 1926], 5,2 g tetrahydrothiopyran-4-olu (již citováno), 50 ml xylenu a 5,5 g bezvodého uhličitanu draselného se míchá a vaří 5 hodin pod zpětným chladičem. Po stání přes noc se směs rozloží 100 ml vody a po rozpuštění anorganických solí se extrahuje benzenem. Extrakt se promyje vodou, vysuší uhličitanem draselným a odpaří za sníženého tlaku. Zbytek (15,8 g) se chromatografuje na koloně 85 g silikagelu. Žádaná látka se eluuje benzenem již v prvních frakcích a získá se ve výtěžku 7,0 g (62 %). Krystaluje z hexanu a v čistém stavu taje při 87,5 až 90 °C.4- (Benzhydryloxy) -1-methyltetrahydro 8.1 g of benzhydryl chloride (Gilman H., Kirby JE: J. Am. Chem. Soc. 48, 1 735, 1926), 5.2 g tetrahydrothiopyran-4-ol (cited above) 50 ml of xylene and 5.5 g of anhydrous potassium carbonate were stirred and refluxed for 5 hours, after standing overnight the mixture was quenched with 100 ml of water and after dissolution of the inorganic salts was extracted with benzene and washed with water, dried with potassium carbonate. The residue (15.8 g) was chromatographed on a column of 85 g of silica gel, eluting with benzene in the first fractions to yield 7.0 g (62%) of crystallization from hexane and pure. melts at 87.5 to 90 ° C.
Příklad 3Example 3
4- (Benzhydryloxy )-l-methyltetrahydrothiopyraniumjodid4- (Benzhydryloxy) -1-methyltetrahydrothiopyranium iodide
Směs 9,3 g 4-(benzhydryloxy jtetrahydrothiopyranu (viz příklad 2), 20 ml methanolu, 30 ml benzenu a 22,8 g methyljodidu se ponechá stát 4 dny při teplotě místnosti.A mixture of 9.3 g of 4- (benzhydryloxy) tetrahydrothiopyran (see Example 2), 20 ml of methanol, 30 ml of benzene and 22.8 g of methyl iodide was allowed to stand at room temperature for 4 days.
Přitom vykrystaluje žádaný produkt ve výtěžku 12,1 g (87 °/o), který se získá filtrací, promytím etherem a vysušením při teplotě místnosti. Rekrystalizaci ze směsi methanolu a benzenu se získá v čistém stavu a má t. t. 151 až 153 °C.The desired product crystallizes in a yield of 12.1 g (87%) which is obtained by filtration, washing with ether and drying at room temperature. Recrystallization from a mixture of methanol and benzene is obtained in the pure state and has a melting point of 151-153 ° C.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS872622A CS259646B1 (en) | 1987-04-13 | 1987-04-13 | Method of diarylmethyl-4-tetrahydrothiopyranyleters and their methiodides preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS872622A CS259646B1 (en) | 1987-04-13 | 1987-04-13 | Method of diarylmethyl-4-tetrahydrothiopyranyleters and their methiodides preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
CS262287A1 CS262287A1 (en) | 1988-02-15 |
CS259646B1 true CS259646B1 (en) | 1988-10-14 |
Family
ID=5363881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS872622A CS259646B1 (en) | 1987-04-13 | 1987-04-13 | Method of diarylmethyl-4-tetrahydrothiopyranyleters and their methiodides preparation |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS259646B1 (en) |
-
1987
- 1987-04-13 CS CS872622A patent/CS259646B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CS262287A1 (en) | 1988-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6323847A (en) | Substituted amino-5,6,7,8-tetrahydronaphthyl- oxyacetic acid | |
RU2154635C2 (en) | Derivatives of 4-aryl-6-aminonicotinic acid and their salts | |
PT88899B (en) | METHOD FOR THE PREPARATION OF TETRAHYDRO-FUR (2,3-C) PYRIDINES AND TETRAHYDRO-THIEN (2,3-C) PYRIDINES AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
CZ43399A3 (en) | Ether muscarine antagonists | |
KR20000022380A (en) | Muscarinic antagonists | |
HU202853B (en) | Process for producing 3-aminodihydrobenzo(b)pyran and benzothiopyran derivatives and pharmaceutical compositions comprising same as active ingredient | |
NL7907040A (en) | NEW DERIVATIVES OF 3- (AMINOETHYL) PHENOL AND THEIR SALTS, METHOD, PREPARATION THEREOF, THE USE THEREOF AS MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THOSE NEW DERIVATIVES. | |
HU185133B (en) | Process for producing 1-hydroxy-octahydro-benzo-bracket-c-bracket closed-quinolines and derivatives | |
CS196893B1 (en) | 3-fluor-10-piperazino-8-substituted 10,11-dihydro-dibenzothiepines | |
JPH02504394A (en) | Stereospecific method for producing furo[3,4-c]pyridine enantiomers, compounds thus obtained and pharmaceutical compositions thereof | |
HUT71132A (en) | Bis-aryl-carbinol derivatives, pharmaceutical compositions containing them and process for producing | |
ZA200502694B (en) | Aplha-phenyl acetanilide derivatives having an acat inhibiting activity and therapeutic application thereof. | |
CS259646B1 (en) | Method of diarylmethyl-4-tetrahydrothiopyranyleters and their methiodides preparation | |
CN100348591C (en) | Substituted methylene pyrones derivatives and their preparing process and use | |
JPH0710863B2 (en) | Novel derivative of 4-OH quinolinecarboxylic acid substituted at position 2 with an etherifiable or esterifiable dihydroxy group, a process for its preparation and its use as a medicament | |
US5736558A (en) | 4-(6-fluoro-1,2-benzisoxazolyl)-1 piperidinyl-propoxy-chromen-4-one-one-derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety | |
US4927819A (en) | Cyclo-octane neuroprotective agents | |
NL8300159A (en) | 3,3-DIALKYL AND 3,3-ALKYLENE-INDOLINE DERIVATIVES, METHODS FOR PREPARING THESE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
CA1209142A (en) | Process for obtaining novel cyanoguanidines and pharmaceutical compositions containing them | |
US4278798A (en) | 1-Ethyl-1,4-dihydro-6-(2-naphthyl)-4-oxonicotinic acid and esters thereof | |
Beccalli et al. | 4-Azidotetronic Acids: A New Class of Azido Derivatives | |
US3432523A (en) | 11,11a - dihydro - 2 - (lower alkyl) - 6 - hydroxy - 6h - benzo(5,6)cyclohept - (1,2,3-cd)indolin-1-ones | |
US4314063A (en) | 1-Ethyl-1,4,5,6-tetrahydro-6-(2-naphthyl)-4-oxo-nicotinic acid and lower alkyl esters thereof | |
CA2065682A1 (en) | 5,7-dihydroxy-2-methyl-8-[4-(3-hydroxy-1-(1-propyl)) piperidiny1]-4h-1-benzopyran-4-one, its preparation and its use | |
VANDERHAEGHE et al. | Phenoxazines. II. 1 10-Dialkylaminoalkylphenoxazines |